Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning-Reference-Cited by-同舟云学术

Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning

Published:2022-01-27 Issue:1 Volume:13 Page:237-256
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Durán Ignacio¹,Castellano Daniel²,Puente Javier³,Martín-Couce Lidia⁴,Bello Esther⁴,Anido Urbano⁵,Mas José Manuel⁶,Costa Luis⁷⁸

Affiliation:

1. Medical Oncology Department, University Hospital Marqués de Valdecilla, IDIVAL, Santander, Spain

2. Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain

3. Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain

4. IPSEN. Planta 7, Torre Realia, L’hospitalet de Llobregat, Barcelona, Spain

5. Department of Medical Oncology, University Clinic Hospital of Santiago, Health Research Institute (IDIS), ONCOMET, Santiago de Compostela, Spain

6. Anaxomics Biotech, Barcelona, Spain

7. Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal

8. Instituto de Medicina Molecular-João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

Publisher

Impact Journals, LLC

Subject

Oncology

Reference89 articles.

1. Corrigendum to "The Epidemiology of Renal Cell Carcinoma" [Eur Urol. 2011; 60:615-21];Kiemeney;Eur Urol,2011

2. Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC);Vano;Cancers (Basel),2021

3. Current and emerging first-line systemic therapies in metastatic clear-cell renal cell carcinoma;Dimitriadis;J BUON,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PD-1/PD-L1 in tumor immunotherapy: Mechanisms and interactions with host growth regulatory pathways;Cytokine & Growth Factor Reviews;2024-10

2. Revolutionizing Immunotherapy: Unveiling New Horizons, Confronting Challenges, and Navigating Therapeutic Frontiers in CAR-T Cell-Based Gene Therapies;ImmunoTargets and Therapy;2024-08

3. Advances in 3D Vascularized Tumor-on-a-Chip Technology;Microfluidics and Biosensors in Cancer Research;2022

4. Cabozantinib combination therapy for the treatment of solid tumors: a systematic review;Therapeutic Advances in Medical Oncology;2022-01